Ketamine is getting attention as a fast-acting option for depression, especially when standard treatments have not helped. Originally used as an anesthetic, it is now offered by some clinicians for treatment-resistant depression, alongside a closely related medicine called esketamine. The honest answer to whether ketamine is a safe depression solution is: it can be safe for many people when it is given in a medical setting with careful screening and ongoing monitoring. It also carries real risks, and it is not the right choice for everyone.
Important: This article is for education only and is not medical advice. If you are in crisis or thinking about self-harm, call or text 988 in the United States or contact emergency services right away.
What Is Ketamine and How Is It Used for Depression?
Ketamine is a prescription medicine. For depression care, it is usually given in one of two ways:
- IV ketamine infusion (often called “ketamine infusion therapy”). This is off-label for depression in the U.S., meaning it is not FDA-approved for depression, but doctors may use it when appropriate.
- Esketamine nasal spray (brand name Spravato). This is FDA-approved for certain patients with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, with strict monitoring requirements.
In clinics, ketamine is typically given over a series of sessions, followed by maintenance visits for some patients. At Luma Wellness Center, sessions are delivered with medical oversight at our San Diego clinic and Temecula clinic, and may be combined with ketamine-assisted psychotherapy for certain patients.
How Does Ketamine Work in the Brain?
Most common antidepressants work on serotonin and norepinephrine and can take weeks to help. Ketamine is different. It affects the brain’s glutamate system and blocks NMDA receptors. Researchers believe this can increase healthy connections between brain cells (sometimes described as improved neuroplasticity). For a deeper dive into the science, see our companion article on ketamine’s unique mechanism of action.
This is one reason ketamine is described as a rapid-acting antidepressant. Some people report symptom relief within hours or a day, although the effect may fade without follow-up care.
Is Ketamine Therapy Real? What Does the Research Say?
Ketamine therapy is real, and it has been studied in people with major depression, including treatment-resistant depression. Research over the last two decades has shown that ketamine can reduce depression symptoms quickly for some patients — sometimes within the same day.
- Fast symptom relief in some patients (often within hours to one day).
- Not a guaranteed response. Some people do not improve.
- Short-lived effect for many patients unless there is a plan for follow-up treatments and ongoing mental health care.
- Ongoing research on the best dose, schedule, and long-term safety.
Is Ketamine Approved for Depression?
Esketamine nasal spray is FDA-approved for certain depression-related uses, and it is administered under a strict safety program (a monitored, in-clinic model). Standard IV ketamine is still commonly used off-label for depression. Approval depends on the formulation. The most important safety factor is medical supervision and appropriate patient screening, no matter which form is used. You can review additional patient education materials on our ketamine resources page.
Safety Concerns: Is Ketamine Safe for Depression?
Ketamine can be safe in a supervised clinical setting, but it is not risk-free. Safety depends on factors like your medical history, your current medications, substance use history, and the clinic’s monitoring standards.
- Short-term side effects (during or soon after treatment), such as dissociation (“feeling detached”), dizziness, nausea, sleepiness, and blurred vision.
- Blood pressure and heart rate increases, which is why clinics usually check vital signs during visits.
- Risk of misuse, since ketamine can be abused outside medical care.
- Uncertainty about long-term effects with repeated use over long periods (research is growing, but questions remain).
Doctors may avoid or use extra caution with ketamine therapy in people with certain heart conditions, uncontrolled high blood pressure, active substance use disorder, untreated psychosis, or other complex medical issues. A qualified clinician should review this with you.
What the Clinical Literature Looks Like
Several published studies have shaped how clinicians think about ketamine for depression:
- Zarate et al. (2006) reported rapid antidepressant effects after a single ketamine infusion in a controlled research setting for treatment-resistant depression.
- Murrough et al. (2013) found that ketamine could reduce depressive symptoms within about a day for some people with treatment-resistant depression, compared with an active placebo control.
- Canuso et al. (2018) studied esketamine in people with major depression and acute suicidal ideation/behavior, showing rapid symptom changes alongside comprehensive clinical care.
Illustrative Patient Vignettes
Vignette 1 — treatment-resistant depression. A middle-aged adult has tried multiple antidepressants and therapy with limited benefit. After medical screening, they begin monitored IV ketamine sessions. They notice a clear lift in mood and less “mental pain” later the same day. Over the following weeks, they continue maintenance visits and focus on sleep, therapy, and relapse-prevention planning.
Vignette 2 — severe symptoms with urgent risk. An adult with major depression has intense, worsening symptoms and safety concerns. In a monitored program, they receive esketamine in clinic alongside frequent follow-ups, safety planning, and adjustments to medication and therapy. They report symptom relief quickly, but still need ongoing care to maintain improvement.
What to Look for in a Ketamine Program
A safe program should be transparent about medical oversight and risks. Practical signs to look for:
- Qualified medical supervision from psychiatry- or anesthesia-trained clinicians.
- Clear screening for heart risks, medication interactions, bipolar disorder, psychosis history, and substance use concerns.
- Monitoring during treatment (vital signs, observation period, and a safe discharge process — no driving right after treatment).
- A full-care plan that includes therapy support, follow-ups, and coordination with your primary mental health provider.
- Honest discussion of benefits, limits, side effects, and costs.
Active-duty service members, veterans, and first responders can also explore our specialized Military, Veterans & First Responders Program.
Bottom Line: Should You Try Ketamine for Depression?
Ketamine may be a helpful option for some people, especially those with treatment-resistant depression, because it can work faster than many standard antidepressants. But it is not a cure, it has real risks, and it works best as part of a broader mental health plan. A good next step is to talk with a qualified clinician who can review your history, explain your options (including therapy and medication choices), and help you decide whether ketamine or esketamine is appropriate.
Related Resources
- Understanding Ketamine’s Unique Mechanism of Action
- Ketamine Treatment Overview
- Ketamine Resources for Patients
- Request a Consultation
References: Zarate CA Jr, et al. (2006). Archives of General Psychiatry. Murrough JW, et al. (2013). American Journal of Psychiatry. Canuso CM, et al. (2018). American Journal of Psychiatry.
